Found: 81
Select item for more details and to access through your institution.
Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96923-2
- By:
- Publication type:
- Article
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00177
- By:
- Publication type:
- Article
Improvement of radioimmunotherapy using pretargeting.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00159
- By:
- Publication type:
- Article
Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15528, doi. 10.3390/ijms232415528
- By:
- Publication type:
- Article
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2564, doi. 10.3390/ijms20102564
- By:
- Publication type:
- Article
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 445, doi. 10.3390/ijms18020445
- By:
- Publication type:
- Article
Immuno-PET for Clinical Theranostic Approaches.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 1, p. 57, doi. 10.3390/ijms18010057
- By:
- Publication type:
- Article
Tumor Immunotargeting Using Innovative Radionuclides.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 2, p. 3932, doi. 10.3390/ijms16023932
- By:
- Publication type:
- Article
Mild sporadic primary hyperparathyroidism: high rate of multiglandular disease is associated with lower surgical cure rate.
- Published in:
- Langenbeck's Archives of Surgery, 2019, v. 404, n. 4, p. 431, doi. 10.1007/s00423-019-01782-1
- By:
- Publication type:
- Article
Management of thyroid nodules incidentally discovered on MIBI scanning for primary hyperparathyroidism.
- Published in:
- Langenbeck's Archives of Surgery, 2015, v. 400, n. 3, p. 313, doi. 10.1007/s00423-015-1286-y
- By:
- Publication type:
- Article
Quality of Life is Modestly Improved in Older Patients with Mild Primary Hyperparathyroidism Postoperatively: Results of a Prospective Multicenter Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 11, p. 3534, doi. 10.1245/s10434-014-3731-5
- By:
- Publication type:
- Article
Quality of Life is Modestly Improved in Older Patients with Mild Primary Hyperparathyroidism Postoperatively: Results of a Prospective Multicenter Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 10, p. 3534, doi. 10.1245/s10434-014-3731-5
- By:
- Publication type:
- Article
Radio-immunothérapie alpha.
- Published in:
- Médecine Sciences, 2016, v. 32, n. 4, p. 362, doi. 10.1051/medsci/20163204014
- By:
- Publication type:
- Article
Does <sup>18</sup>fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up?
- Published in:
- Head & Neck, 2007, v. 29, n. 12, p. 1115, doi. 10.1002/hed.20645
- By:
- Publication type:
- Article
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 12, p. 4590, doi. 10.1210/jc.2007-0938
- By:
- Publication type:
- Article
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 11, p. 6077, doi. 10.1210/jc.2005-0044
- By:
- Publication type:
- Article
From a PMT-based to a SiPM-based PET system: a study to define matched acquisition/reconstruction parameters and NEMA performance of the Biograph Vision 450.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40658-020-00323-w
- By:
- Publication type:
- Article
Prospective Multicentric Assessment of 68 Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 513, doi. 10.3390/cancers15020513
- By:
- Publication type:
- Article
Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2721, doi. 10.3390/cancers12092721
- By:
- Publication type:
- Article
Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2424, doi. 10.3390/cancers12092424
- By:
- Publication type:
- Article
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1512, doi. 10.3390/cancers12061512
- By:
- Publication type:
- Article
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1282, doi. 10.3390/cancers11091282
- By:
- Publication type:
- Article
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.714514
- By:
- Publication type:
- Article
Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1202, doi. 10.1002/cncr.10286
- By:
- Publication type:
- Article
Laparoscopic sentinel lymph node dissection in prostate cancer patients: the additional value depends on preoperative data.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 10, p. 1849, doi. 10.1007/s00259-016-3397-2
- By:
- Publication type:
- Article
F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 8, p. 1501, doi. 10.1007/s00259-014-2772-0
- By:
- Publication type:
- Article
Pretargeted radioimmunotherapy: clinically more efficient than conventional radioimmunotherapy?
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Laparoscopic sentinel lymph node (SLN) versus extensive pelvic dissection for clinically localized prostate carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 2, p. 291, doi. 10.1007/s00259-011-1975-x
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 9, p. 1669, doi. 10.1007/s00259-010-1471-8
- By:
- Publication type:
- Article
Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 7, p. 1270, doi. 10.1007/s00259-010-1417-1
- By:
- Publication type:
- Article
Analysis of <sup>18</sup>F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin’s lymphoma: a reflection of disease infiltration or just inflammation?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 11, p. 1813, doi. 10.1007/s00259-009-1183-0
- By:
- Publication type:
- Article
Consolidation radioimmunotherapy of follicular lymphoma: a step towards cure?
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 7, p. 1236, doi. 10.1007/s00259-008-0727-z
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 3, p. 637, doi. 10.1007/s00259-007-0625-9
- By:
- Publication type:
- Article
A pretargeting system for tumor PET imaging and radioimmunotherapy.
- Published in:
- Frontiers in Pharmacology, 2015, v. 6, p. 1, doi. 10.3389/fphar.2015.00054
- By:
- Publication type:
- Article
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 156, doi. 10.2967/jnumed.123.265872
- By:
- Publication type:
- Article
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1706, doi. 10.2967/jnumed.123.265871
- By:
- Publication type:
- Article
New Developments in Myeloma Treatment and Response Assessment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1331, doi. 10.2967/jnumed.122.264972
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 257, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Molecular signature of FDG-PET biomarkers in newly diagnosed multiple myeloma patients: a genomewide transcriptome analysis from the CASSIOPET study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.262884
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.236000
- By:
- Publication type:
- Article